Defects of somatic hypermutation and class switching in alymphoplasia (aly) mutant mice
- PMID: 8757952
- DOI: 10.1093/intimm/8.7.1067
Defects of somatic hypermutation and class switching in alymphoplasia (aly) mutant mice
Abstract
The alymphoplasia (aly) mutation of mice causes the systemic absence of lymph nodes, Peyer's patches and well-defined lymphoid follicles in the spleen. We found that antibody responses are elicited, albeit weakly, to either T cell-dependent or T cell-independent antigen by aly/aly mutants. However, isotype switching was defective. The T cell-dependent immune response was not elicited in splenectomized aly/aly mice. Neither hypermutation nor germinal center formation was observed in aly/aly mice. These results suggest that T-B collaboration requires either lymph nodes or spleen, and that hypermutation and affinity maturation depend on germinal center formation.
Similar articles
-
Alymphoplasia (aly)-type nuclear factor kappaB-inducing kinase (NIK) causes defects in secondary lymphoid tissue chemokine receptor signaling and homing of peritoneal cells to the gut-associated lymphatic tissue system.J Exp Med. 2000 May 1;191(9):1477-86. doi: 10.1084/jem.191.9.1477. J Exp Med. 2000. PMID: 10790423 Free PMC article.
-
Intestinal gamma delta T cells develop in mice lacking thymus, all lymph nodes, Peyer's patches, and isolated lymphoid follicles.J Immunol. 2005 Feb 15;174(4):1906-12. doi: 10.4049/jimmunol.174.4.1906. J Immunol. 2005. PMID: 15699117
-
A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice.Eur J Immunol. 1994 Feb;24(2):429-34. doi: 10.1002/eji.1830240224. Eur J Immunol. 1994. PMID: 8299692
-
Role of TNF ligand and receptor family in the lymphoid organogenesis defined by gene targeting.J Med Invest. 1999 Aug;46(3-4):141-50. J Med Invest. 1999. PMID: 10687308 Review.
-
Primary immunodeficiency syndromes.Adv Exp Med Biol. 2010;685:146-65. doi: 10.1007/978-1-4419-6448-9_14. Adv Exp Med Biol. 2010. PMID: 20687503 Review.
Cited by
-
NF-κB inducing kinase: a key regulator in the immune system and in cancer.Cytokine Growth Factor Rev. 2010 Aug;21(4):213-26. doi: 10.1016/j.cytogfr.2010.06.002. Epub 2010 Aug 3. Cytokine Growth Factor Rev. 2010. PMID: 20685151 Free PMC article. Review.
-
Secondary lymphoid organs contribute to, but are not required for the induction of graft-versus-host responses following allogeneic bone marrow transplantation: a shifting paradigm for T cell allo-activation.Biol Blood Marrow Transplant. 2010 May;16(5):598-611. doi: 10.1016/j.bbmt.2009.12.007. Epub 2010 Feb 1. Biol Blood Marrow Transplant. 2010. PMID: 20117226 Free PMC article.
-
Pathological role of tonsillar B cells in IgA nephropathy.Clin Dev Immunol. 2011;2011:639074. doi: 10.1155/2011/639074. Epub 2011 Jul 18. Clin Dev Immunol. 2011. PMID: 21785618 Free PMC article. Review.
-
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus.Nat Commun. 2018 Jan 12;9(1):179. doi: 10.1038/s41467-017-02672-0. Nat Commun. 2018. PMID: 29330524 Free PMC article.
-
TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1.Elife. 2015 Dec 23;4:e10592. doi: 10.7554/eLife.10592. Elife. 2015. PMID: 26701909 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases